160 related articles for article (PubMed ID: 32941706)
1. Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients.
Rojko L; Megyesfalvi Z; Czibula E; Reiniger L; Teglasi V; Szegedi Z; Szallasi Z; Dome B; Moldvay J
Thorac Cancer; 2020 Nov; 11(11):3193-3204. PubMed ID: 32941706
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies.
Soyano AE; Dholaria B; Marin-Acevedo JA; Diehl N; Hodge D; Luo Y; Manochakian R; Chumsri S; Adjei A; Knutson KL; Lou Y
J Immunother Cancer; 2018 Nov; 6(1):129. PubMed ID: 30470260
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer.
Wang B; Chen S; Xiao H; Zhang J; Liang D; Shan J; Zou H
Cancer Med; 2022 Jan; 11(1):268-280. PubMed ID: 34799997
[TBL] [Abstract][Full Text] [Related]
4. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
[TBL] [Abstract][Full Text] [Related]
5. Impact of CyberKnife Radiosurgery on Overall Survival and Various Parameters of Patients with 1-3 versus ≥ 4 Brain Metastases.
Murovic J; Ding V; Han SS; Adler JR; Chang SD
Cureus; 2017 Oct; 9(10):e1798. PubMed ID: 29282442
[TBL] [Abstract][Full Text] [Related]
6. Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
Abu-Shawer O; Abu-Shawer M; Hirmas N; Alhouri A; Massad A; Alsibai B; Sultan H; Hammo H; Souleiman M; Shebli Y; Al-Hussaini M
BMC Cancer; 2019 Feb; 19(1):141. PubMed ID: 30755184
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Blood Biomarkers Associated with Clinical Outcome in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
Tanizaki J; Haratani K; Hayashi H; Chiba Y; Nakamura Y; Yonesaka K; Kudo K; Kaneda H; Hasegawa Y; Tanaka K; Takeda M; Ito A; Nakagawa K
J Thorac Oncol; 2018 Jan; 13(1):97-105. PubMed ID: 29170120
[TBL] [Abstract][Full Text] [Related]
8. Absolute Neutrophil Count and Mean Platelet Volume in the Blood as Biomarkers to Detect Lung Cancer.
Zhu X; Chen Y; Cui Y
Dis Markers; 2020; 2020():1371964. PubMed ID: 32377267
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study.
MacDougall K; Niazi MRK; Hosry J; Homsy S; Bershadskiy A
Oncology (Williston Park); 2022 Mar; 36(3):156-161. PubMed ID: 35298118
[TBL] [Abstract][Full Text] [Related]
10. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy.
Joseph N; McWilliam A; Kennedy J; Haslett K; Mahil J; Gavarraju A; Mistry H; Van Herk M; Faivre-Finn C; Choudhury A
Radiother Oncol; 2019 Jun; 135():115-119. PubMed ID: 31015156
[TBL] [Abstract][Full Text] [Related]
11. The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study.
Karantanos T; Karanika S; Seth B; Gignac G
Clin Transl Oncol; 2019 Feb; 21(2):206-212. PubMed ID: 29948974
[TBL] [Abstract][Full Text] [Related]
12. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
Sert F; Cosgun G; Yalman D; Ozkok S
Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
[TBL] [Abstract][Full Text] [Related]
13. Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer.
Goto W; Kashiwagi S; Takada K; Asano Y; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
Anticancer Res; 2022 Feb; 42(2):939-946. PubMed ID: 35093893
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors.
Pu D; Xu Q; Zhou LY; Zhou YW; Liu JY; Ma XL
Thorac Cancer; 2021 Nov; 12(21):2914-2923. PubMed ID: 34581010
[TBL] [Abstract][Full Text] [Related]
15. The clinical potential of circulating immune cell counts in primary gastric lymphoma.
Haimour A; Abu-Shawer O; Abu-Shawer M; Al-Taji A; Altamimi T; Mansour R; Amarin JZ; Sultan H; Al-Hussaini M
J Gastrointest Oncol; 2021 Apr; 12(2):365-376. PubMed ID: 34012632
[TBL] [Abstract][Full Text] [Related]
16. The clinical value of peripheral immune cell counts in pancreatic cancer.
Abu-Shawer O; Abu-Shawer M; Shurman A; Lattouf A; Haimour A; Hamdan O; Mansour R; Altamimi T; Al-Hussaini M
PLoS One; 2020; 15(6):e0232043. PubMed ID: 32542007
[TBL] [Abstract][Full Text] [Related]
17. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of D-dimer in lung cancer.
İnal T; Anar C; Polat G; Ünsal İ; Halilçolar H
Clin Respir J; 2015 Jul; 9(3):305-13. PubMed ID: 24720709
[TBL] [Abstract][Full Text] [Related]
19. Hematologic markers of distant metastases in gastric cancer.
Abu-Shawer O; Abu-Shawer M; Haimour A; Alhouri A; Alkhatib AA; Abki M; Alqaisi O; Hamdan O; Alsaqri R; Ismail S; Altamimi T; Al-Hussaini M
J Gastrointest Oncol; 2019 Jun; 10(3):529-536. PubMed ID: 31183204
[TBL] [Abstract][Full Text] [Related]
20. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
